Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension

Authors: Coca A.¹; Calvo C.; Sobrino J.; Lopez-Paz J.; Sierra C.; Gomez E.; Bragulat E.; de la Sierra A.

Source: Clinical Therapeutics, Volume 25, Number 11, November 2003 , pp. 2849-2864(16)

Publisher: Elsevier

Keywords: irbesartan/hydrochlorothiazide fixed combination; hypertension; ambulatory blood pressure monitoring; trough-to-peak ratio; smoothness index

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(03)80338-7

Affiliations: 1: Hospital Clinico IDIBAPS, University of Barcelona, , Barcelona, Spain

Links for this article

http://www.ingentaconnect.com/els/01492918/2003/00000025/00000011/art80338
http://openurl.ingenta.com/content?genre=article&issn=0149-2918&volume=25&issue=11&spage=2849&epage=2864
http://dx.doi.org/10.1016/S0149-2918(03)80338-7